Sumaiya Sharmeen counsels clients in complex IP litigation matters in the life sciences, biotechnology, medical device, and pharmaceutical industries.

A partner in the firm’s Intellectual Property Group, Sumaiya leverages her technical background in medical biophysics and biotechnology to represent life sciences and technology companies in complex trade secrets and patent disputes. Her legal practice involves preparing infringement, validity, and damages analyses and serving as counsel in fact and expert depositions, motion practice, hearings, and trials across multiple forums. She has counseled clients through “patent dance” in Biologics Price Competition and Innovation Act (BPCIA) proceedings, and has advised clients on successful strategies for engaging in BPCIA and Hatch-Waxman Act matters. She also advises clients on patent portfolio development, pre-suit investigations, and strategic IP counseling.

Sumaiya has significant experience in disputes involving gene therapy, monoclonal antibodies, antibody-drug conjugates, recombinant protein manufacturing and purification processes, and small-molecule inhibitors.

Prior to joining the firm, Sumaiya practiced IP litigation and strategic IP counseling in Toronto, representing clients across biotechnology, pharmaceuticals, and information technology matters.

Sumaiya is admitted to practice in California and Ontario (Canada). In addition to her legal and scientific degrees, she earned a certificate in artificial intelligence from UC Berkeley Law.